Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025)

Zhengye Biotechnology Holding has reported Total Current Liabilities over the past 3 years, most recently at $17.0 million for Q4 2025.

  • Quarterly Total Current Liabilities fell 10.22% to $17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Dec 2025, down 10.22% year-over-year, with the annual reading at $17.2 million for FY2025, 7.46% down from the prior year.
  • Total Current Liabilities was $17.0 million for Q4 2025 at Zhengye Biotechnology Holding, down from $18.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $20.9 million in Q4 2023 and troughed at $17.0 million in Q4 2025.
  • The 3-year median for Total Current Liabilities is $18.9 million (2024), against an average of $18.9 million.
  • Year-over-year, Total Current Liabilities fell 9.32% in 2024 and then dropped 10.22% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $20.9 million in 2023, then fell by 9.32% to $18.9 million in 2024, then dropped by 10.22% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Total Current Liabilities are $17.0 million (Q4 2025), $18.8 million (Q2 2025), and $18.9 million (Q4 2024).